Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do not have discriminative stimulus properties

Daniel M. Hutcheson, Fazal Subhan, David M. Pache, Rafael Maldonado, Marie Claudé Fournié-Zaluski, Bernard P. Roques, Robert D.E. Sewell*

*Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Analgesic doses of the enkephalin degrading enzyme inhibitor RB 120 do not have discriminative stimulus properties'. Together they form a unique fingerprint.

Medicine & Life Sciences